CoChat

Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

A 50-year-old woman who had previously undergone right hemicolectomy and chemotherapy for colorectal cancer was hospitalized with respiratory failure. Chest computed tomography showed reticulonodular opacities and enlarged lymph nodes. A transbronchial biopsy revealed adenocarcinoma with epidermal growth factor receptor (EGFR) mutations T790M and L861Q. Treatment with the EGFR-tyrosine kinase inhibitor (TKI) osimertinib was started, and she achieved a partial response. We diagnosed her with metastatic lung tumors from colorectal cancer based on additional immunohistochemical staining and the EGFR mutation status (L861Q) of the specimens. Although cases with EGFR mutations have been rarely reported, an EGFR-TKI can be an effective treatment option for colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2169/internalmedicine.0002-22

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Surgical specimens of colorectal cancer.
Figure 1. Surgical specimens of colorectal cancer.CC BY-NC-ND · PubMed Central
Figure 2. Chest computed tomography shows diffuse reticulonodular opacities and thickened interlobular septal walls (a), multiple enlarged lymph nodes (b), and bilateral pleural effusions (c). Yellow triangles indicate the enlarged lymph node.
Figure 2. Chest computed tomography shows diffuse reticulonodular opacities and thickened interlobular septal walls (a), multiple enlarged lymph nodes (b), and bilateral pleural effusions (c). Yellow triangles indicate the enlarged lymph node.CC BY-NC-ND · PubMed Central
Figure 3. (a) Biopsy specimen from the enlarged mediastinal lymph node. (b) Immunohistochemical staining of the mediastinal lymph node. CDX2: caudal-related homeobox transcription factor 2, CK20: cytokeratin 20, CK7: cytokeratin 7, TTF-1: thyroid transcription factor-1
Figure 3. (a) Biopsy specimen from the enlarged mediastinal lymph node. (b) Immunohistochemical staining of the mediastinal lymph node. CDX2: caudal-related homeobox transcription factor 2, CK20: cytokeratin 20, CK7: cytokeratin 7, TTF-1: thyroid transcription factor-1CC BY-NC-ND · PubMed Central
Figure 4. Clinical course. The dagger symbol indicates the time of death. HFNC: high-flow nasal cannula
Figure 4. Clinical course. The dagger symbol indicates the time of death. HFNC: high-flow nasal cannulaCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 8

Metadata

Authors
Yanagisawa, A., Kinehara, Y., Kijima, R., Tanaka, M., Ninomiya, R., Jokoji, R., & Tachibana, I.
Affiliations
Nippon Life Hospital (JP)
Venue
Internal Medicine
Published
2023-03-01
Volume
62
Issue
5
Pages
769-773
ISSN
  • 0918-2918 (ISSN-L)
  • 1349-7235
OpenAlex
W4286384836
Cited by
7
References
19
Citations by year
2025: 3 · 2024: 2 · 2023: 2
FWCI
1.13
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Internal Medicine (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Metastasis and carcinoma case studies
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
colorectal cancer, lung metastasis, EGFR mutation, osimertinib, EGFR tyrosine kinase inhibitors, T790M, L861Q, adenocarcinoma, immunohistochemistry, partial response, hemicolectomy
MeSH terms
Acrylamides, Aniline Compounds, Female, Humans, Indoles, Lung Neoplasms, Middle Aged, Mutation, Pyrimidines, Colorectal Neoplasms, Protein Kinase Inhibitors, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib. https://app.cochat.ai/papers/10.2169/internalmedicine.0002-22
The paper
Yanagisawa, A., Kinehara, Y., Kijima, R., Tanaka, M., Ninomiya, R., Jokoji, R., & Tachibana, I. (2023). Metastatic Lung Tumors from Colorectal Cancer with EGFR Mutations That Responded to Osimertinib. Internal Medicine. https://doi.org/10.2169/internalmedicine.0002-22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.